Arkolith/Insider Trading/GENB/Form 4

Nally Michael

Chief Executive Officer, DirectorGenerate Biomedicines, Inc. (GENB) · full profile →Form 4 · filed Mar 6, 2026
Net Buying
Open-Market Buys
$240K
Open-Market Sells
$0
Net Open-Market Flow
$240K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 4, 2026Buy(P)20K$12.00$240K573K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-096799) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML